The store will not work correctly when cookies are disabled.
(3-tert-Butyl-pyrrolidin-1-yl)-(4-hexyloxy-phenyl)-methanone
ID: ALA121822
PubChem CID: 10892912
Max Phase: Preclinical
Molecular Formula: C21H33NO2
Molecular Weight: 331.50
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCOc1ccc(C(=O)N2CCC(C(C)(C)C)C2)cc1
Standard InChI: InChI=1S/C21H33NO2/c1-5-6-7-8-15-24-19-11-9-17(10-12-19)20(23)22-14-13-18(16-22)21(2,3)4/h9-12,18H,5-8,13-16H2,1-4H3
Standard InChI Key: MFKDNMHZILMJII-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
6.6292 -3.5500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1125 -3.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7042 -4.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2917 -4.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5917 -3.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1792 -3.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5375 -4.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1042 -2.6542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5875 -3.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5917 -4.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0750 -3.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -4.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0750 -4.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -3.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0375 -4.4625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1875 -5.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1292 -4.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8292 -5.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5167 -4.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0000 -4.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4417 -4.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9542 -4.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4792 -4.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9167 -4.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 1 0
5 2 1 0
6 1 1 0
7 4 1 0
8 2 2 0
9 6 1 0
10 5 1 0
11 5 2 0
12 14 2 0
13 10 2 0
14 11 1 0
15 12 1 0
16 7 1 0
17 7 1 0
18 7 1 0
19 15 1 0
20 19 1 0
21 22 1 0
22 23 1 0
23 20 1 0
24 21 1 0
9 4 1 0
13 12 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.50 | Molecular Weight (Monoisotopic): 331.2511 | AlogP: 5.15 | #Rotatable Bonds: 7 |
Polar Surface Area: 29.54 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.13 | CX LogD: 5.13 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.65 | Np Likeness Score: -0.93 |
References
1. Lloyd J, Schmidt JB, Rovnyak G, Ahmad S, Atwal KS, Bisaha SN, Doweyko LM, Stein PD, Traeger SC, Mathur A, Conder ML, DiMarco J, Harper TW, Jenkins-West T, Levesque PC, Normandin DE, Russell AD, Serafino RP, Smith MA, Lodge NJ.. (2001) Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers., 44 (23): [PMID:11689063] [10.1021/jm015505u] |